Telehealth Interventions for Caregiver Well-being
(WellCAST Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are actively in treatment that overlaps with the trial's offerings, you may not be eligible to participate.
What data supports the effectiveness of the treatment Telehealth Interventions for Caregiver Well-being?
Is Acceptance and Commitment Therapy (ACT) safe for caregivers?
How is the Telehealth Interventions for Caregiver Well-being treatment different from other treatments for caregiver support?
This treatment is unique because it uses telehealth to deliver various evidence-based therapies like ACT, CICBT, and DBT remotely, making it more accessible and convenient for caregivers who may face geographical or logistical barriers to in-person therapy. The use of telehealth allows for flexible, culturally informed, and self-guided interventions that have been shown to improve caregiver well-being and reduce problem behaviors in care recipients.1011121314
What is the purpose of this trial?
The goal of this clinical trial is to learn which types of telehealth-based treatments best fit the needs of caregivers of people with rare neurogenetic conditions. The main questions it plans to answer are:* Which telehealth support programs best meet the needs of rare disorder caregivers?* How can individuals be matched to support programs that are right for them? What aspects of an individual (e.g., demographics, mental health symptoms, family characteristics, lifestyle) predict whether treatment will be a good fit?* Does peer-to-peer coaching help improve patients' experiences during telehealth treatment?Participants will be asked to complete a 12-week treatment program, which may include self-guided resources, individual therapies, group therapies, and/or peer-to-peer coaching.Before, during, and after treatment, participants will complete questionnaires to help researchers understand their experiences, symptoms, and impressions of their support program. Questionnaires will include both standard forms (administered up to 5 times throughout the study) and brief "snapshot surveys" that participants complete on their smartphones up to 3 times per day.Some participants will be assigned to a waitlist control, which means that they will provide data while they are not yet completing a support program. These participants will be assigned to a support program in the next treatment phase.
Research Team
Bridgette Kelleher, PhD
Principal Investigator
Purdue University
Eligibility Criteria
This trial is for caregivers and legal guardians of children aged 2-35 with neurogenetic conditions that cause moderate to severe intellectual disability. Participants must live in the US, be fluent in English, and seek support for their mental health or caregiving needs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Caregivers complete initial study forms and 'snapshot surveys' sent three times per day via smartphones
Treatment
Participants complete a 12-week telehealth support program, which may include self-guided resources, individual therapies, group therapies, and/or peer-to-peer coaching
Follow-up
Participants complete follow-up forms and a 2-week period of 'snapshot surveys' to assess changes post-treatment
Treatment Details
Interventions
- Acceptance and Commitment Therapy (ACT)
- Culturally Informed Cognitive Behavioral Therapy (CICBT)
- Dialectical Behavioral Therapy (DBT)
- Durand Sleep Intervention
- Naturalistic Communication Intervention (NCI)
- Participation Enhancement Intervention (PEI)
- RUBI Intervention
- Self-Guided Resources
Find a Clinic Near You
Who Is Running the Clinical Trial?
Purdue University
Lead Sponsor
University of Virginia
Collaborator
University of Canterbury
Collaborator
University of Oregon
Collaborator
Georgia State University
Collaborator
University of Missouri-Columbia
Collaborator
Indiana University
Collaborator